Logo image of ORTX

ORCHARD THERAPEUTICS PLC-ADR (ORTX) Stock Analyst Ratings

NASDAQ:ORTX - Nasdaq - US68570P2002 - ADR - Currency: USD

16.7  +0.05 (+0.3%)

Buy % Consensus

46

ChartMill assigns a Buy % Consensus number of 46% to ORTX. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 16.32. This target is -2.28% below the current price.
ORTX was analyzed by 7 analysts. The buy percentage consensus is at 46. So analysts seem to be rather neutral about ORTX.
In the previous month the buy percentage consensus was at a similar level.
ORTX was analyzed by 7 analysts. More opinions would make the average more meaningful.

Related screens

ORTX Historical Analyst RatingsORTX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -61 -55 -49 -43 -37 -31 -25 -19 -13 -7 -1 5 10 15

Price Target & Forecast

Price Low Median Mean High 16.7016.1616.3216.3216.80 - -3.23% -2.28% -2.28% 0.60%

Related screens

ORTX Current Analyst RatingORTX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2023-10-05 Stifel Downgrade Buy -> Hold
2023-08-09 Oppenheimer Reiterate Outperform -> Outperform
2023-06-27 Cantor Fitzgerald Reiterate Overweight -> Overweight
2023-06-13 Oppenheimer Maintains Outperform -> Outperform
2023-03-28 Cantor Fitzgerald Maintains Overweight
2022-05-13 Barclays Maintains Overweight
2021-11-16 JP Morgan Downgrade Neutral -> Underweight
2021-11-05 Oppenheimer Maintains Outperform
2021-08-18 JP Morgan Downgrade Overweight -> Neutral